INTRODUCTION {#S1}
============

Embryonic development in all animals begins with the maternal-to-zygotic transition (MZT) (reviewed in [@R93]; [@R102]). The MZT can be divided into two phases: initially, maternally supplied RNAs and proteins direct embryonic development; subsequently, activation of transcription from the zygotic genome, a process termed "zygotic genome activation" (ZGA), transfers developmental control from the mother's genome to that of the embryo. During the first phase, post-transcriptional regulation of maternal transcripts and post-translational regulation of maternal proteins predominate. The former is coordinated by RNA-binding proteins (RBPs), which regulate the translation, stability, and localization of the maternal transcripts. A large proportion of maternal mRNA species is degraded in a highly coordinated manner during the MZT ([@R1]; [@R19]; [@R52]; [@R88]; [@R91]; [@R95]; [@R98]). Transcriptome-wide changes in the translational status of mRNAs have also been described ([@R13]; [@R22]; [@R78]; [@R90]; [@R104]; [@R107]), and global changes in the proteome have been documented ([@R5]; [@R7]; [@R11]; [@R25]; [@R31]; Kronja et al., 2014; [@R72]; [@R88]; [@R92]).

Relevant to the changes in the proteome is the ubiquitin-proteasome system, which is a highly conserved and widespread pathway for specific targeting of proteins for degradation ([@R48]; [@R77]). This is accomplished through the E1-E2-E3 enzyme ubiquitination cascade, with the E3 ubiquitin ligase acting as the substrate-specificity factor, which transfers ubiquitin from an E2 ubiquitin-conjugating enzyme to specific target proteins ([@R73]; [@R114]). Regulation of protein stability by the ubiquitin-proteasome system during the MZT has been noted in several studies. For example, MG132-directed inhibition of maternal protein degradation in mouse early zygotes delays ZGA ([@R39]). Also, in mouse, loss of an E3 ubiquitin ligase, RNF114, prevents development beyond the two-cell stage ([@R110]). RNF114-directed ubiquitination and clearance of TAB1 permit nuclear factor-kB (NF-kB) pathway activation, although why this is necessary for the MZT is not known. In *C. elegans*, E3-ligase-directed clearance of the RBPs, OMA-1 and OMA-2, in the early embryo is crucial for the temporal coordination of ZGA ([@R20]; [@R35]; [@R47]; [@R83]; [@R100]).

In *Drosophila melanogaster*, Smaug (SMG), a multifunctional RBP, is essential for both maternal mRNA degradation and ZGA ([@R8]). SMG protein accumulates rapidly at the onset of embryogenesis, when the Pan gu (PNG) kinase complex abrogates translational repression of the *smg* and *Cyclin B* (as well as many other) mRNAs ([@R50]; [@R95]; [@R101]). SMG binds target mRNAs through a stem-loop structure known as the SMG recognition element (SRE) ([@R2], [@R3]). Through these elements, SMG induces degradation and/or represses the translation of a large subset of the maternal transcripts ([@R13]; [@R81], [@R82]; [@R95]; [@R111]). SMG downregulates target mRNA expression through the recruitment of proteins that influence how these mRNAs interact with the mRNA decay and translation machineries. For example, SMG recruits the CCR4-NOT deadenylase complex to induce transcript degradation ([@R81]) and the *Drosophila* miRNA Argonaute (AGO), AGO1, to repress mRNA translation ([@R74]). SMG acts in a complex with additional translational repressors, including the eIF4E-binding protein, Cup; the DEAD-box heli-cases, Maternal expression at 31B (ME31B) and Belle (BEL); and the FDF-domain protein, Trailer hitch (TRAL) ([@R30]; [@R44]; [@R63], [@R64]; [@R65]; [@R105], [@R106]). PNG is required for the degradation of the Cup, TRAL, and ME31B repressors in early embryos ([@R104]), and at least one of these, TRAL, may be a direct substrate of PNG ([@R37]). SMG protein itself is rapidly degraded at the end of the MZT ([@R8]; [@R85]), but the mechanisms and functions of SMG clearance are unknown.

Leveraging the increasing sensitivity and measurement quality of multiplexed proteomics ([@R69]; [@R86]), we present here a quantification of the developmental proteome of the *Drosophila* embryo. We show that the embryonic proteome represents over half of the protein-coding capacity of the genome, and thus is more than 40% larger than previously defined ([@R11]). We highlight a distinct cluster of proteins, comprising 2% of the maternally contributed embryonic proteome, that is highly expressed at the beginning of the MZT, but then rapidly degraded. This cluster includes SMG, Cup, TRAL, and ME31B. Focusing on these four repressors, we find that degradation of Cup, TRAL, and ME31B begins early and continues throughout the MZT, whereas SMG is degraded more abruptly and later, toward the end of the MZT. We identify two distinct E3 ubiquitin ligase complexes that target clearance of these proteins through the ubiquitin proteasome: the C-terminal to Lis1 Homology (CTLH) complex, which is homologous to the yeast Gid complex ([@R28]; [@R53]), targets Cup, TRAL, and ME31B; and the Skp/Cullin/F-box-containing (SCF) complex ([@R40]) targets SMG. We then engineer a stable version of the SMG protein that does not undergo degradation at the end of the MZT and show that persistent SMG downregulates zygotic re-expression of a subset of its maternal targets. Thus, clearance of SMG is necessary for this aspect of the MZT.

RESULTS {#S2}
=======

Definition and Dynamics of the Embryonic Proteome {#S3}
-------------------------------------------------

We performed quantitative complement tandem mass tag (TMTc+) mass spectrometry (MS) ([@R87]) on the proteome of embryos at three stages that encompass the MZT, as well as at two later stages: (1) early syncytial blastoderm, prior to ZGA; (2) early nuclear cycle 14 (NC14) during blastoderm cellularization, after high-level ZGA; (3) germ-band extension, representing the end of the MZT; (4) germ-band retraction, representing mid-embryogenesis; and (5) tracheal filling, shortly before the end of embryogenesis ([Table S1](#SD2){ref-type="supplementary-material"}). We chose TMTc+ for this analysis because, in comparison with label-free methods, it generates data with higher measurement precision and overcomes the "missing value" problem ([@R69]). TMTc+ also eliminates ratio compression, which is a common problem in other multiplexed proteomics approaches ([@R69]; [@R86]; [@R99]). Importantly, due to the employed multiplexed proteomics approach, low signal in a condition is easy to interpret as low protein abundance. This is a major advantage over label-free measurements (for example, [@R11]) in which absence of signal could be caused by low abundance or because the mass spectrometer randomly did not detect the protein of interest ([@R69]). We used BACIQ ([@R71]) to assign confidence to the relative expression of proteins at every stage ([Table S1](#SD2){ref-type="supplementary-material"}).

In total, we detected 7,956 unique proteins encoded by 7,683 genes ([Table S1](#SD2){ref-type="supplementary-material"}), representing 55% of the protein-coding genome (7,683/13,918 per FlyBase Release 6.03) ([@R60]). We captured 97% of previously identified embryonically expressed proteins (5,186/5,359 genes) ([@R11]), as well as proteins encoded by an additional 2,294 genes ([Figure 1A](#F1){ref-type="fig"}). This increases the size of the embryonic proteome by 43%. The newly detected proteins are significantly less abundant than those reported previously (Wilcoxon rank-sum test, p \< 10 ^−4^; [Figure 1A](#F1){ref-type="fig"}).

To reveal classes of proteins with distinct expression dynamics during and after the MZT, we carried out k-means clustering of relative protein expression ([Figure 1B](#F1){ref-type="fig"}; [Table S1](#SD2){ref-type="supplementary-material"}). A majority (65%) of proteins were present throughout the MZT and later embryogenesis, undergoing less than 2-fold increases or decreases in relative levels over the time course (clusters 1 and 2: 2,607 and 2,406 proteins, respectively). These either represent stable maternally encoded proteins, which are predominantly already deposited in the egg, similar to what has been observed in frog embryos ([@R72]), or proteins whose rates of synthesis and degradation are similar, thereby resulting in relatively constant levels ([@R49]). Proteins in clusters 3, 4, and 5 (1,123; 887; and 779 proteins, respectively) underwent significant increases in distinct waves: proteins in cluster 4 increased in levels during the MZT, reaching a peak at mid-embryogenesis and then declining somewhat thereafter. Proteins in cluster 5 increased in levels after the MZT and continued to rise throughout the rest of embryogenesis. Proteins in cluster 3 increased in levels at mid-embryogenesis and continued to increase thereafter. Strikingly, there was only one cluster that underwent a significant decrease in relative levels: 154 proteins were highest at the first time point and rapidly decreased to very low relative levels by the end of the MZT (cluster 6). Several members of cluster 6 have previously been shown to be cleared by the end of the MZT; examples include String ([@R21]), Twine ([@R26]), BIGH1 ([@R70]), PNG ([@R27]), and Plutonium ([@R23]).

Gene Ontology (GO) term analysis was conducted on each of the six clusters using the DAVID bioinformatics resource ([@R41], [@R42]) ([Table S2](#SD3){ref-type="supplementary-material"}). Cluster 1 showed enrichment for terms related to the ubiquitin-proteasome system, as well as core biological processes, such as DNA replication and cell division. Cluster 2 was enriched for terms related to core components of mitochondrial function, endoplasmic reticulum (ER) and Golgi, transcription, splicing, and translation. Enrichment of clusters 1 and 2 for core cellular and molecular functions is consistent with the constant requirement for these components throughout development.

Cluster 4 was enriched for terms related to chromatin, sequence-specific DNA binding, transcriptional regulation, cell fate specification, and morphogenesis, consistent with the fact that ZGA is known to be required to produce transcription factors that specify cell fate and pattern starting at the cellular blastoderm stage (reviewed in [@R102]). Cluster 5 was enriched for terms related to cell adhesion and several morphogenetic processes (tube formation, heart, neuromuscular junction), consistent with the sculpting of tissues and organs after the MZT. Cluster 3 was enriched for terms related to chitin production and secretion, myogenesis, and synaptogenesis, consistent with a role for these proteins during the final stages of embryonic development and the secretion of the larval cuticle prior to hatching from the egg.

Cluster 6 was unusual in that relative expression was highest at the earliest stage of embryogenesis, following which its proteins were rapidly degraded to low levels by the end of the MZT ([Figures 1B](#F1){ref-type="fig"} and [1C](#F1){ref-type="fig"}). A previous study of the embryonic proteome detected 104 of these 154 proteins ([@R11]). We compared the change in level of these proteins in the two datasets and found that 93% (97/104) were depleted in both datasets ([Figure 1D](#F1){ref-type="fig"}). The degradation of only a small fraction of maternally loaded proteins stands in striking contrast with maternally loaded mRNA species, two-thirds of which are degraded by the end of the MZT ([@R98]).

Cluster 6 proteins must be either largely maternally supplied and already present in the oocyte, or rapidly synthesized from maternal mRNAs after egg activation or fertilization; we refer to them as "maternal" proteins. This cluster showed enrichment for GO terms related to the eggshell, as well as cytoplasmic ribonucleoprotein (RNP) granules (defined as non-membranous macromolecular complexes containing proteins and mRNAs), germ plasm, and germ cell development ([Table S2](#SD3){ref-type="supplementary-material"}). Because these RNP components are present during the first phase of the MZT, when gene expression is regulated primarily post-transcriptionally, it is plausible that they participate in these processes. Indeed, four components of the SMG-mediated repressor complex, SMG, Cup, TRAL, and ME31B, belong to cluster 6 ([Figure 1C](#F1){ref-type="fig"}). These and several other RBPs in cluster 6 are known to have important functions in post-transcriptional regulation during the MZT.

To determine whether proteins in cluster 6 share an amino acid sequence motif that may provide insight into the mechanisms regulating their precise temporal degradation, we used the Multiple Em for Motif Elicitation (MEME) tool through The MEME Suite (<http://meme-suite.org/>) ([@R4]). Using cluster 1 proteins as a negative set, we found enrichment for several low-complexity motifs in cluster 6, notably poly-alanine and poly-glutamine tracts ([Figure S1A](#SD1){ref-type="supplementary-material"}). RBPs are known to be rich in intrinsically disordered regions ([@R103]), and there is enrichment of RBPs in cluster 6. To overcome this possible bias, we re-ran MEME using as a negative set only the 394 annotated RBPs and RNP-associated proteins in cluster 1 and, again, found enrichment for glutamine-rich motifs ([Figure S1B](#SD1){ref-type="supplementary-material"}). This motif was found in 34 of the 154 cluster 6 proteins and, thus, is unlikely, by itself, to explain degradation of the entire cluster. We conclude that there is no single, simple protein motif that distinguishes the rapidly degraded maternal cluster 6 proteins from co-expressed maternal proteins that are stable through the MZT.

Dynamics of the Proteome Relative to the Transcriptome and Translatome during the MZT {#S4}
-------------------------------------------------------------------------------------

We next compared the relative changes in the proteome (this study) with those previously identified for either the RNA population ("transcriptome") or for ribosome-associated mRNAs ("translatome") ([@R22]) at equivalent time points across the MZT. We focused on cluster 4 (newly synthesized during the MZT) and cluster 6 (degraded during the MZT). A previous study that compared the embryonic proteome and transcriptome excluded almost all proteins in cluster 6 from their analysis because of these proteins' narrow expression window ([@R7]).

A significant proportion of mRNAs encoding proteins in cluster 4 underwent increases in RNA levels and ribosome association at comparable time points (Fisher's exact test, p \< 10^−9^ and p \< 10 ^−3^, respectively; [Figures 1E](#F1){ref-type="fig"} and [1G](#F1){ref-type="fig"}). However, whereas a significant proportion of the cluster 6 unstable maternal proteins underwent a concomitant decrease in cognate mRNA levels (Fisher's exact test, p \< 10 ^−22^; [Figure 1F](#F1){ref-type="fig"}), there was no correlation with changes in ribosome association (Fisher's exact test, p = 0.206; [Figure 1H](#F1){ref-type="fig"}). This last result is consistent with the fact that some of the cluster 6 proteins, such as SMG, are synthesized during the MZT rather than during oogenesis; thus, their cognate mRNAs exhibit high ribosome association despite the fact that their encoded proteins are subsequently rapidly cleared.

In summary, the subset of proteins that undergoes extensive increases in levels during the MZT (cluster 4) shows parallel increases in both mRNA level and translation efficiency. In contrast, the subset that decreases rapidly during the MZT (cluster 6) undergoes parallel decreases in levels of cognate mRNAs, but not translation efficiency.

Maternal Ribonucleoprotein Complex Components Are Degraded during the MZT {#S5}
-------------------------------------------------------------------------

A closer examination of the cluster 6 RNP granule proteins revealed different decay profiles during the MZT. Of the 17 RBPs and RNP-associated proteins in cluster 6, several were cleared from the embryo very rapidly and were depleted by the second time point. These included Cup, TRAL, and ME31B (highlighted in [Figure 1C](#F1){ref-type="fig"}), as well as BicaudalC, Swallow, Wispy, Cp7Fa, and Spargel. Others underwent most of their degradation between the second and third time points, including SMG (shown in [Figure 1C](#F1){ref-type="fig"}), Vasa, Oskar, and Tudor. Seven of the 17 RBPs contained one or more of the MEME-identified polyalanine or poly-glutamine motifs described above. Note that not all maternally loaded RBPs fell into cluster 6; several were stable and fell into clusters 1 or 2 (e.g., Brain tumor, Pumilio, Rasputin, Egalitarian, BEL, PABP; see [Table S1](#SD2){ref-type="supplementary-material"}).

To verify the results of the MS and to assess the dynamics of SMG, Cup, TRAL, and ME31B expression at higher temporal resolution, we carried out western blot analysis of extracts from embryos collected in overlapping 30-min intervals through the first 6 h of embryogenesis ([Figures 2A](#F2){ref-type="fig"} and [S2](#SD1){ref-type="supplementary-material"}). Cup, TRAL, and ME31B are maternally supplied proteins with highest expression at the onset of embryogenesis ([@R11]; [@R92]; [@R104]). Our analysis showed that these proteins decline in parallel, coincident with degradation of their cognate transcripts ([@R104]). Degradation started early, even before 1 h, and its completion at approximately 2.5 h coincided with early NC14. Whereas Cup fell below the limit of detection, TRAL and ME31B persisted at reduced levels (nearly 10% based on quantification of the western blot). Disappearance of Cup and persistence of low levels of ME31B and TRAL were also visible in the MS analysis ([Figure 1C](#F1){ref-type="fig"}). In contrast with these three proteins, SMG protein expression was low at the onset of embryogenesis and peaked at about 1 h, corresponding with rapid translational derepression of the maternally loaded *smg* transcripts upon egg activation ([@R95]). SMG then persisted at more or less constant levels before undergoing precipitous degradation between about 2.5 and 3 h ([@R8]; [@R11]), coinciding with blastoderm cellularization and high-level ZGA. Disappearance of SMG was nearly complete, as judged both from western blotting and our MS analysis ([Figures 1C](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}, and [S2](#SD1){ref-type="supplementary-material"}; [Table S1](#SD2){ref-type="supplementary-material"}). Two additional proteins associated with the *nanos* repressor complex ([@R30]; [@R44]) were also assessed: the DEAD-box helicase, BEL, and the cap-binding protein, eIF4E. Levels of BEL remained fairly constant (67% remained at 4 h), whereas eIF4E gradually decreased in abundance but was clearly detectable throughout the time course (19% remained after 4 h). The results of our western blot analyses of BEL and eIF4E are consistent with both our own MS data and published datasets ([@R11]; [@R92]; [@R104]).

Previous studies have shown that the clearance of SMG protein from the embryo depends on ZGA ([@R8]). To determine the role of ZGA in the degradation of Cup, TRAL, and ME31B, we analyzed their expression (as well as that of SMG, as a control) in activated, unfertilized eggs, which carry out maternally directed post-transcriptional and post-translational processes, but do not undergo transcriptional activation ([@R6]; [@R68]; [@R94]). Embryo extracts were collected from wild-type mated and unmated females in 1-h intervals over 4 h, and expression of the RBPs was assayed by western blotting ([Figure 2B](#F2){ref-type="fig"}). The clearance of Cup, TRAL, and ME31B was unaffected in unfertilized eggs, indicating that their degradation is not dependent on ZGA. In contrast and as expected, SMG protein was stable in unfertilized eggs ([@R8]). Thus, Cup-TRAL-ME31B and SMG differ both in the timing of their degradation and in whether they require zygotically synthesized gene products to accomplish this process.

Degradation of the Repressors Is Regulated by the Ubiquitin-Proteasome System {#S6}
-----------------------------------------------------------------------------

To determine whether clearance of SMG, Cup, TRAL, and ME31B occurs via the ubiquitin-proteasome system, we inhibited the proteasome in developing embryos using the small molecule, MG132. 1- to 2-h-old embryos were permeabilized ([@R76]) and incubated with either MG132 or control buffer, then allowed to develop for a further 3 h. Western blots on controls showed that SMG, Cup, TRAL, and ME31B were degraded as expected. Strikingly, treatment with 100 mM MG132 resulted in stabilization of all four RBPs ([Figure 2C](#F2){ref-type="fig"}).

If the ubiquitin-proteasome system indeed targets these proteins for degradation, it should be possible to identify specific sites of ubiquitination. In MS analysis of tryptic protein digests, ubiquitination is visible as a lysine to which the two C-terminal glycine residues of ubiquitin are attached; often, the modified lysine residue is not cleaved by trypsin. A reanalysis of our previous MS data ([@R30]) revealed ubiquitination signatures in all four repressors ([Table S3](#SD4){ref-type="supplementary-material"}).

Together these data support a role for the ubiquitin-protea-some in clearance of SMG, Cup, TRAL, and ME31B proteins during the MZT.

Two Distinct Ubiquitin Ligase Complexes Interact with the Repressors {#S7}
--------------------------------------------------------------------

To identify the specific E3 ligases that regulate degradation of the repressors during the MZT, we performed immunoprecipitation followed by mass spectrometry (IP-MS) from transgenic embryos expressing FLAG-tagged SMG protein and used Significance Analysis of Interactome (SAINT) to characterize interactors of SMG ([@R15]). As expected, Cup, TRAL, and ME31B, as well as BEL and eIF4E, were highly enriched in FLAG-SMG IPs relative to control IPs, placing them among the top interactors ([Figure 3A](#F3){ref-type="fig"}; [Table S4](#SD5){ref-type="supplementary-material"}) and recapitulating the known repressive complex ([@R30]; [@R44]). We note that these RBPs were also detected, albeit at much lower levels, in our control IPs, likely as a result of some level of nonspecific interaction exacerbated by the very high expression levels of these RBPs at this stage of embryogenesis. In addition, we captured RNA-independent interactions with several members of two distinct multi-subunit E3 ubiquitin ligase complexes: the SCF complex and the CTLH complex ([Figure 3B](#F3){ref-type="fig"}; [Table S4](#SD5){ref-type="supplementary-material"}). SCF complex components that were identified included core components such as SKPA (Skp) and CUL1 (Cullin), as well as SLMB and CG14317 (F-box proteins) ([@R77]), whereas the CTLH complex was represented by all of the characterized *Drosophila* subunits ([@R28]): RanBPM, Muskelin, CG6617, CG3295, CG7611, and CG31357 ([Figure 3B](#F3){ref-type="fig"}; [Table S4](#SD5){ref-type="supplementary-material"}). Detection of the CTLH complex confirmed earlier data ([@R30]).

To verify the interaction of these two E3 ligase complexes with the repressors, we performed an independent set of reciprocal IP-MS experiments using embryos expressing GFP-SLMB or Muskelin-GFP. Muskelin-GFP IPs from RNase-treated extracts were highly enriched for additional members of the CTLH complex and for the four repressors ([Figure 3C](#F3){ref-type="fig"}; [Table S5](#SD6){ref-type="supplementary-material"}). Variation in the amount of Muskelin IPed between biological replicates resulted in the enrichment of several CTLH subunits having significance only at p \< 0.1 ([Figure 3C](#F3){ref-type="fig"}). GFP-SLMB pull-downs from RNase-treated extracts captured highly significant enrichment relative to control (p \< 0.01) for additional subunits of the SCF complex, as well as the four repressors ([Figure 3D](#F3){ref-type="fig"}; [Table S5](#SD6){ref-type="supplementary-material"}). The association of all four repressors with both E3 ligase complexes presumably reflects the formation of stable repressor complexes.

Degradation of Cup, TRAL, and ME31B Is Directed by the CTLH E3 Ubiquitin Ligase {#S8}
-------------------------------------------------------------------------------

The CTLH complex has previously been shown to copurify with the SMG-Cup-TRAL-ME31B repressive complex ([@R30]), but the functional significance of this interaction has not been elucidated; neither has a role for the CTLH been identified in any other biological process in *Drosophila*. The SCF complex has been implicated in multiple processes, including the cell cycle, control of cell polarity, cell-cell signaling, and the germ plasm (see, for example, [@R62]; [@R67]; [@R108]), but a possible role during the MZT has not been studied.

To investigate the role of the SCF and the CTLH E3 ubiquitin ligase complexes in degradation of the repressors during the MZT, we performed maternal RNAi knockdown experiments for several core members of the SCF and CTLH complexes. Embryos were collected at 1-h intervals from female flies with germline knockdown, and expression of SMG, Cup, TRAL, and ME31B was assessed by western blot over the first 4 h of embryogenesis. Knockdown was confirmed in these embryos by qRT-PCR and, in the case of SLMB, also by western blot ([Figures 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [S3](#SD1){ref-type="supplementary-material"}, and [S6](#SD1){ref-type="supplementary-material"}).

Individual maternal knockdown of the CTLH complex members Muskelin, RanBPM, or CG3295 resulted in stabilization of Cup, TRAL, and ME31B proteins ([Figures 4A](#F4){ref-type="fig"}--[4C](#F4){ref-type="fig"}), whereas SMG protein degradation was unaffected ([Figure 4D](#F4){ref-type="fig"}). In these experiments, knockdown of the CTLH complex components also resulted in a delay in the degradation of *cup, tral*, and *me31B* transcripts ([Figure S4](#SD1){ref-type="supplementary-material"}). DAPI staining of the RNAi embryos revealed a developmental delay in a subset (about 20%). To eliminate the possibility that developmentally delayed or arrested embryos contributed to repressor protein "persistence," we visualized embryo development live under halocarbon oil and picked embryos at three specific developmental stages during the MZT for analysis: stage 2 (0.5--1 h of embryogenesis), stage 5b (2.5 h of embryogenesis), and stage 7b (3 h of embryogenesis). Developmentally delayed or abnormal embryos were thus excluded by this method. Knockdown of any of the three members of the CTLH complex led to nearly complete stabilization of Cup, TRAL, and ME31B through to stage 7b, whereas in controls, all three proteins were degraded by stage 5b ([Figure S5](#SD1){ref-type="supplementary-material"}). qRT-PCR quantification of mRNA expression in these staged embryos showed that *cup* mRNA was cleared from the embryo by stage 7b both in knockdown and in control embryos. This result excludes new synthesis as the reason for the persistence of Cup under conditions of CTLH complex knockdown, thus providing strong evidence that the CTLH complex is required for degradation of the Cup protein ([Figure S5](#SD1){ref-type="supplementary-material"}). However, *tral* and *me31B* transcripts were partially stabilized in stage 7b embryos ([Figure S5](#SD1){ref-type="supplementary-material"}); thus, we cannot rule out the possibility that translation from their stabilized cognate transcripts contributes in part to the persistence of TRAL and ME31B protein. Either way, it is clear that the CTLH plays a key role in clearance of Cup and, likely, also TRAL and ME31B, but not in clearance of SMG.

Degradation of SMG Is Directed by the SCF E3 Ubiquitin Ligase {#S9}
-------------------------------------------------------------

In contrast with the CTLH complex, we found that maternal knockdown of the SCF complex members CUL1, SKPA, or SLMB had no effect on Cup, TRAL, and ME31B expression but resulted in stabilization of SMG protein ([Figure 5](#F5){ref-type="fig"}). Furthermore, we confirmed by qRT-PCR that degradation of *smg* mRNA, which is coincident with SMG protein's clearance, was unaffected in these embryos ([Figure S7](#SD1){ref-type="supplementary-material"}). Thus, persistence of SMG in the absence of the SCF E3 ligase complex must have been a result of protein stabilization. Finally, to exclude the possibility that stabilization of SMG was a result of a developmental delay resulting from these knockdowns, we performed immunostaining of SMG in the RNAi embryos. Whereas SMG normally disappears from the bulk cytoplasm of embryos prior to gastrulation, in knockdown of core members of the SCF complex, we found gastrulating embryos ubiquitously staining for high levels of SMG protein ([Figure S7](#SD1){ref-type="supplementary-material"}).

Taken together, these data provide strong evidence that the SCF E3 ubiquitin ligase complex regulates degradation of SMG protein at the end of the MZT, whereas the CTLH complex directs degradation of Cup, TRAL, and ME31B.

Temporal Regulation of the E3 Ligase Complexes {#S10}
----------------------------------------------

What determines the timing of E3 ligase complex action? We assessed the dynamics of CTLH and SCF subunits in our TMTc+ MS data and found that, with the exceptions described below, the subunits detected (CTLH: RanBPM, CG3295, CG6617, CG7611, CG31357; SCF: CUL1, SKPA, ROC1a, SLMB) were present throughout embryogenesis ([Figure 6](#F6){ref-type="fig"}). These results are consistent with cluster 1 proteins showing enrichment for the GO term "ubiquitin-proteasome system."

In contrast with the other CTLH subunits, the relative level of Muskelin decreased rapidly during the MZT ([Figure 6A](#F6){ref-type="fig"}), consistent with previous MS results ([@R11]). We confirmed this expression profile by western blotting of GFP-tagged Muskelin and comparison with endogenous CG3295 ([Figure 6B](#F6){ref-type="fig"}). Furthermore, our re-analysis of previously published data ([@R30]) revealed that Muskelin is ubiquitinated in early embryos ([Table S3](#SD4){ref-type="supplementary-material"}). The role of Muskelin in the function of the CTLH complex is unknown; however, these data are consistent with the possibility that the dynamics of Muskelin clearance might restrict CTLH function to the early phase of the MZT, coinciding with the timing of Cup, TRAL, and ME31B degradation.

For the SCF complex, our TMTc+ MS showed that the CUL1, SKPA, ROC1a, and SLMB subunits were present at relatively constant levels throughout embryogenesis ([Figure 6C](#F6){ref-type="fig"}), and western blots confirmed that SLMB is expressed throughout the MZT ([Figure 6D](#F6){ref-type="fig"}). The F-box subunit confers substrate specificity to the SCF complex, and SLMB is one of two F-box proteins that we found to interact with SMG by IP-MS ([Figure 3B](#F3){ref-type="fig"}). Strikingly, the second F-box protein, CG14317, displayed a highly unusual expression pattern: the CG14317 mRNA is absent at the beginning of embryogenesis, is zygotically expressed, peaking during the late MZT, and then drops precipitously ([@R9]; [@R32]). The mRNA is not detected at any other stage of *Drosophila* development, neither is it found in any tissue or cell line that has been profiled (<http://flybase.org/reports/FBgn0038566>). Both our ([Figure 6C](#F6){ref-type="fig"}) and previously published MS data ([@R11]) showed that the CG14317 protein follows an almost identical expression pattern to that of its cognate mRNA; thus, CG14317 is expressed when SMG protein degradation is triggered. Furthermore, degradation of SMG near the end of the MZT depends on zygotic transcription, and CG14317 mRNA and protein are produced zygotically. We speculate that CG14317 could serve as a timer for SCF action on SMG (see [Discussion](#S12){ref-type="sec"}).

Persistent SMG Protein Downregulates Zygotic Re-expression of Its Target Transcripts {#S11}
------------------------------------------------------------------------------------

The SMG RBP contains a dimerization domain near its N terminus ([@R96]) and a SAM-PHAT RNA-binding domain toward the C terminus ([@R2], [@R3]). We produced transgenic fly lines expressing FLAG-p53-tagged SMG, either full-length ("FLAG-SMG") or missing the C-terminal 233 amino acids ("FLAG-SMG767D999") ([Figure 7A](#F7){ref-type="fig"}). FLAG-SMG767D999 is deleted for two of the three ubiquitination sites detected in our MS ([Table S3](#SD4){ref-type="supplementary-material"}); the third site resides in the SAM-PHAT domain, just N-terminal to the deletion. The transgenes were under control of the endogenous *smg* gene's regulatory elements and, to avoid potential complications resulting from dimerization of transgenic FLAG-SMG with endogenous SMG, all assays were conducted in the *smg*^*47*^ null mutant background ([@R13]).

To assess whether the deletion reduced interaction with the SCF E3 ligase, we carried out IP-MS of FLAG-SMG and FLAG-SMG767D999. The deletion showed a striking reduction of interaction with the F-box proteins SLMB and CG14317 relative to full-length SMG ([Table S4](#SD5){ref-type="supplementary-material"}): whereas SLMB and CG14317 were readily detected for full-length FLAG-SMG, respectively, with SAINT scores of 1.0 (Bayesian false discovery rate \[BFDR 0.0\]) and 0.96 (BFDR 0.0), they were completely undetected in the FLAG-SMG767D999 IP-MS.

Next, we assessed the effect of the deletion on protein stability and found that truncation of SMG's C-terminal 233 amino acids led to stabilization of the protein throughout the MZT ([Figure 7B](#F7){ref-type="fig"}). We conclude that the truncated SMG protein has significantly decreased SCF interactions, and that this correlates with failure to clear the protein at the end of the MZT.

This positioned us to study the effects of persistent SMG. SMG is known to target hundreds of maternal transcripts for degradation during the MZT ([@R13]; [@R95]). A subset of these transcripts is re-expressed upon ZGA ([@R8]; [@R19]; [@R98]). Given that the CCR4-NOT deadenylase complex, through which SMG is known to destabilize its target mRNAs, remains expressed at fairly constant levels throughout embryogenesis (cluster 1; also, see [@R97]), we hypothesized that persistent SMG protein may result in unintentional targeting of zygotically re-expressed SMG targets. To test this hypothesis, we compared transcript dynamics in *smg*^*47*^ mutant embryos expressing either full-length FLAG-SMG or FLAG-SMG767D999. Gene expression was assayed by qRT-PCR in 0- to 2.5-h-old embryos (representing the maternal phase of the MZT) and 2.5- to 5-h-old embryos (representing the zygotic phase of the MZT).

Embryos that lack SMG protein fail to undergo both maternal mRNA decay and ZGA ([@R8]; [@R95]). We, therefore, first carried out two control experiments to assess whether FLAG-SMG767D999 rescues these processes. One control focused on strictly zygotic transcripts that lack SMG binding sites ([@R8]). We found that these were expressed at comparable (or even higher; Wilcoxon signed rank test, p \< 0.02) levels for FLAG-SMG767D999 versus full-length FLAG-SMG, showing that FLAG-SMG767D999 rescues ZGA ([Figure 7C](#F7){ref-type="fig"}). A second control analyzed degradation of SMG-bound maternal transcripts that are targeted by SMG but are not re-expressed zygotically ([@R13]; [@R95]). We found that these were degraded in FLAG-SMG767D999 embryos, sometimes (*Frip84*, *FBXO11*, *Rpn2*, *Rpn7*) to even lower levels than in embryos expressing full-length SMG (Wilcoxon signed rank test, p \< 3 × 10^−3^; [Figure 7D](#F7){ref-type="fig"}). Thus, FLAG-SMG767D999 also rescues maternal mRNA decay. Finally, we assayed the expression of transcripts that met three criteria: (1) maternally supplied and degraded in a SMG-dependent manner ([@R95]), (2) directly bound by SMG ([@R13]), and (3) zygotically re-expressed at high levels upon initiation of ZGA ([@R8]). Strikingly, *smg*^*47*^ embryos expressing FLAG-SMG767D999 showed significantly lower zygotic expression of these transcripts when compared with *smg*^*47*^ embryos expressing full-length FLAG-SMG (Wilcoxon signed rank test, p \< 4 × 10^−3^; [Figure 7E](#F7){ref-type="fig"}).

We conclude that precise temporal regulation of SMG protein degradation at the end of the MZT is required to permit proper zygotic re-expression of transcripts with SMG binding sites.

DISCUSSION {#S12}
==========

Here we have shown that, in *Drosophila*, an extremely small subset of its maternal proteome is cleared during the MZT. This contrasts with the massive degradation of the maternal mRNA transcriptome that occurs during the MZT of all animals (reviewed in [@R102]). Previous studies in other animals have suggested that the maternal proteome may behave very differently from the maternal transcriptome during the MZT. For example, in *C. elegans*, a quarter of the transcriptome is downregulated, whereas only 5% of the proteome shows a similar decrease ([@R88]). In frog embryos, there is also a discordance between the temporal patterns of protein and mRNA ([@R72]).

The set of proteins cleared during the *Drosophila* MZT is enriched for RNP granule components. This is consistent with the importance of post-transcriptional processes during the first ("maternal") phase of the MZT and the possible need to downregulate these processes upon ZGA and the switch to zygotic control of development. By focusing on a subset of these RNP components, which function as post-transcriptional repressors, we have uncovered precise temporal control of their clearance by two distinct E3 ubiquitin ligase complexes: the SCF E3 ligase governs the degradation of SMG, whereas the CTLH E3 ligase is responsible for the degradation of Cup, TRAL, and ME31B. Intriguingly, SMG is degraded later during the MZT compared with its co-repressors Cup, TRAL, and ME31B. We have also shown that clearance of SMG is essential for appropriate levels of re-expression of a subset of its targets during ZGA. Our results raise questions about how temporal specificity of protein degradation is regulated, as well as why at least two temporally distinct mechanisms of protein degradation exist during the MZT.

Expression data support the hypothesis that timing of E3 ligase function might, at least in part, be determined by the timing of expression of one or more of their component subunits, notably Muskelin for CTLH and CG14317 for S*CF.* During the *Drosophila* MZT, most components of the CTLH complex display constant expression levels, but Muskelin protein is degraded with a similar profile to its target repressors. Mammalian Muskelin has been shown to be auto-ubiquitinated and targeted for degradation ([@R58]). Our detection of a ubiquitinated peptide in Muskelin supports the possibility that the *Drosophila* CTLH complex may be negatively autoregulated through its Muskelin subunit during the MZT. In contrast, activation of CTLH function at the beginning of the MZT may not depend on changes in complex composition: previous studies have shown that going from stage 14 oocytes to activated eggs or early (0--1 h) embryos, there are no significant changes in either the levels of CTLH subunit proteins (including Muskelin) or the ribosome association of their cognate transcripts ([@R22]; [@R50]). Thus, we speculate that post-translational modification of one or more CTLH subunits may activate CTLH function.

Modification of substrates may also play a role: the degradation of Cup, TRAL, and ME31B depends on the PNG kinase ([@R104]), which itself has temporally restricted activity coinciding with degradation of these repressors ([@R36]). PNG-dependent phosphorylation of Cup, TRAL, and ME31B may make them ubiquitination substrates. Furthermore, evidence suggests that temporal regulation of the E2 ubiquitin-conjugating enzyme, UBC-E2H, at this stage depends on the PNG kinase and may also contribute to the timing of ubiquitin ligase complex function during the MZT ([@R112]). Concomitant PNG-dependent activation of the CTLH complex, its cognate E2, and its substrates, coupled with subsequent self-inactivation of the complex through Muskelin degradation, would provide a precise time window for CTLH function and, therefore, for degradation of Cup, TRAL, and ME31B early in the MZT.

In contrast with these three co-repressors, degradation of SMG occurs near the end of the MZT and depends on zygotic gene expression. Although the levels of most SCF complex subunits are constant during the MZT, the F-box protein CG14317 displays a unique expression pattern: CG14317 protein and mRNA are absent at the beginning of the MZT, are zygotically synthesized, peak in NC14 embryos, and sharply decline shortly thereafter. Thus, CG14317 expression coincides with the timing of SMG protein degradation and, coupled with the zygotic nature of its accumulation, makes it a strong candidate to be a timer for SCF function. The fact that knockdown of SLMB stabilizes SMG protein suggests that both F-box proteins may be necessary for SMG degradation, with CG14317 serving as the timer. At present there are no forward or reverse genetic reagents available to test this hypothesis. Additionally, the function of SLMB in directing SMG-protein ubiquitination may itself be temporally restricted. Both *Drosophila* SLMB and its mammalian homolog are known to bind phosphorylated motifs ([@R29]; [@R45]). Phosphorylated residues have been detected in SMG in the embryo, including residues within its C terminus ([@R113]); one of these, S967, resides close to a ubiquitinated lysine, K965 ([Table S3](#SD4){ref-type="supplementary-material"}). In summary, despite the stable expression of SLMB during the MZT, temporal regulation of phosphorylation of its target proteins, including SMG, through yet uncharacterized mechanisms, may also contribute to temporal control of SMG protein degradation.

Because Cup, TRAL, and ME31B are known to function as co-repressors in a complex with SMG ([@R30]; [@R44]; [@R65]), why are the timing of degradation of Cup-TRAL-ME31B and SMG differentially regulated? Although the SMG-Cup-TRAL-ME31B-mRNA complex has been characterized to be extremely stable *in vitro* ([@R44]), it would be disrupted *in vivo* by the degradation of Cup, TRAL, and ME31B (or by the degradation of *nos* and other SMG-target mRNAs). SMG directs translational repression both through AGO1 and through Cup-TRAL-ME31B, as well as transcript degradation through recruitment of the CCR4-NOT deadenylase ([@R13]; [@R65]; [@R74]; [@R81]; [@R95]; [@R111]). CTLH-driven degradation of Cup, TRAL, and ME31B would abrogate SMG-Cup-TRALME31B-dependent translational repression, but not AGO1-dependent repression, because AGO1 levels increase during the MZT ([@R57]). However, the relative contributions of AGO1 versus Cup-TRAL-ME31B to translational repression by SMG are unknown. That said, the CCR4-NOT deadenylase is present both during and after the MZT ([@R97]); thus, SMG-dependent transcript degradation would occur both before and after clearance of Cup, TRAL, and ME31B. 12% of SMG-associated transcripts are degraded, but not repressed, by SMG ([@R13]). Perhaps this subset is bound and degraded by SMG late in the MZT, after the drop in Cup, TRAL, and ME31B levels.

Another possible role for clearance of ME31B and TRAL derives from studies in budding yeast, where it has been shown that their orthologs, respectively, Dhh1p and Scd6p, have a potent inhibitory effect on "general" translation ([@R16]; [@R66]; [@R75]). If this is also true in *Drosophila*, then degradation of ME31B and TRAL, which are present at exceedingly high concentrations in embryos ([@R30]), might also serve to permit high-level translation during the second phase of the MZT ([@R104]).

We previously showed that SMG has both direct and indirect roles in the MZT. SMG's direct role is to bind to a large number of maternal mRNA species and target them for repression and/or degradation ([@R13]; [@R95]). Two indirect effects have been shown in *smg* mutants. First, if maternal transcripts fail to be degraded and/or repressed, ZGA fails or is significantly delayed, likely because mRNAs encoding transcriptional repressors persist ([@R8]; [@R57]). Second, because zygotically synthesized microRNAs direct a second wave of maternal mRNA decay during the late MZT, in *smg* mutants, failure to produce those microRNAs results in failure to eliminate a second set of maternal transcripts late in the MZT ([@R8]; [@R57]).

Here we have uncovered a role for rapid clearance of the SMG protein itself late in the MZT: to permit normal levels of zygotic re-expression of a subset of it targets. Notably, stabilized SMG (SMG767D999) rescues both clearance of its maternal targets and ZGA, excluding the possibility that lower-than-normal levels of re-expressed targets are a result of defective SMG function upon deletion of its C terminus. Indeed, in our control experiments, SMG's exclusively maternal targets actually dropped to lower levels than normal, likely because SMG767D999 continues to direct their decay beyond when SMG normally disappears from embryos. Furthermore, in our other control, strictly zygotic transcripts that lack SMG binding sites were expressed at higher levels in SMG767D999-rescued mutants than in full-length SMG-rescued mutants. This result is consistent with the hypothesis that clearance of transcriptional repressors by SMG permits ZGA ([@R8]); persistent SMG would clear these repressors to lower levels than normal, hence resulting in higher zygotic expression. The higher-than-normal expression of zygotic transcripts that lack SMG binding sites makes the lower-than-normal levels of SMG's zygotically re-expressed target transcripts by SMG767D999 even more striking. Together, these data support a model in which the timing of both SMG synthesis and clearance are important for orderly progression of the MZT.

STAR★METHODS {#S13}
============

RESOURCE AVAILABILITY {#S14}
---------------------

### Lead Contact {#S15}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Howard Lipshitz (<howard.lipshitz@utoronto.ca>).

### Materials Availability {#S16}

Materials generated for this study are available on request from Howard Lipshitz (<howard.lipshitz@utoronto.ca>).

### Data and Code Availability {#S17}

The raw data associated with the mass spectrometry experiments presented in this study have been deposited to the ProteomeX-change Consortium (<http://www.proteomexchange.org/>). Embryo developmental proteome (deposited via the PRIDE partner repository) with accession number ProteomeXchange: PXD016523; GFP-SLMB and Muskelin-GFP IP-MS (deposited via the PRIDE partner repository) with accession number ProteomeXchange: PXD018794; FLAG-SMG IP-MS (deposited via the MassIVE partner repository) with accession number ProteomeXchange: PXD019280.

Source data used for analyses in [Figures 1A](#F1){ref-type="fig"} and [1D](#F1){ref-type="fig"} in the paper are available from [@R11] Table S11; <https://doi.org/10.1101/gr.213694.116>. Source data used for analyses in [Figures 1E](#F1){ref-type="fig"}--[1H](#F1){ref-type="fig"} are available from [@R22] Supplementary File 2; <https://doi.org/10.7554/eLife.16955>.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S18}
--------------------------------------

*Drosophila melanogaster* strains were cultivated under standard laboratory conditions at 25°C unless otherwise indicated. 'Wild-type' strains included Canton S and *w*^*1118*^. Strains for GFP IP-MS experiments were: *UAS:GFP-Slimb-6/CyO* (gift from Daniel St Johnston, Cambridge); *w\*; P{UAS-muskelin.GFP}attP2* (Bloomington D*rosophila* Stock Center \[BDSC\] \#65860); *nos-GAL4: w*^*1118*^*; P{GAL4::VP16-nos.UTR}CG6325MVD1* (gift from Martine Simonelig, Montpellier; BDSC \#4937). RNAi strains against mRNAs encoding proteins of interest were from the Transgenic RNAi Project (TRiP) and were obtained from BDSC: Muskelin (\#51405), RanBPM (\#61172), CG3295 (\#61896), CUL1 (\#36601), SKPA (\#32991), SLMB (\#33898). mCherry RNAi was used as control (gift from T. Hurd; BDSC \#35785). The maternal-GAL4 driver used was *y*^*1*^ *w\*; P{matalpha4-GAL-VP16}67; P{matalpha4-GAL-VP16}1*5 (BDSC \#80361). Flies expressing FLAG-tagged SMG transgenes were generated in this study (See [Method Details](#S19){ref-type="sec"}) and crossed to the *smg*^*47*^ deletion mutant strain ([@R13]).

Embryos used for experiments were collected and aged at 25°C unless otherwise indicated. Cages containing male and female adult *Drosophila* were set up with apple juice agar plates supplemented with yeast paste. For unfertilized egg collection, unmated females were used, and males were housed in an adjacent cage, separated by mesh, to promote egg laying. Flies were allowed to acclimatize in cages for at least one day prior to embryo collection, and plates were changed once in the morning and once in the evening to ensure proper developmental staging. After egg lay and development to the desired age on the apple juice agar plates, embryos were harvested for further processing and experiments.

METHOD DETAILS {#S19}
--------------

### Embryo developmental proteome {#S20}

#### Embryo collection {#S21}

Each sample of \~ 300 *w*^*1118*^ embryos was collected over a period of 1 hour at 22°C, then aged to the desired stage at the same temperature: (1) as early as possible -- sample was not aged, the median time of this collection was defined as 0 min (2) Cycle 14 -- 190 min; (3) germ-band extension -- 330 min; (4) germ-band retraction -- 630 min; and (5) trachea filling -- 1290 min. Excess yeast and any dead flies were removed from the surface of the plates. The embryos were dechorionated with 2.5% sodium hypochlorite (50% bleach) solution for 1 min, filtered through a nylon mesh and rinsed under water for 2 minutes to wash off the chorions. Embryos on the mesh were manually counted under the stereo microscope then transferred to a 1.5mL tube containing 100 mL PBST (1x PBS containing 0.1% Tween-20). All stages were confirmed by visualizing a random sample of 30 embryos under the stereo microscope (Zeiss Stemi 2000) in halocarbon 27 oil. The embryos were spun down using a mini-centrifuge, and the excess PBST was removed. The embryos were then flash frozen in liquid nitrogen until lysis.

#### Embryo lysis and MS sample preparation {#S22}

Sample was prepared as detailed previously ([@R34]). Each condition (corresponding to different stages) was lysed in \~150 mL 7M Urea, 2M Thiourea, 2% Sodium dodecyl sulfate (SDS), 1 tablet per 10ml Protease inhibitor (88666, Thermo Fisher), 5mM Dithiothreitol (DTT) and 50mM HEPES(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), pH7.2. The embryos were lysed by tip-sonication (FB50, Fisher Scientific): 10 pulses with 10 s on, 20 s off (on ice) at 50% amplitude. Disulfide bonds were reduced by adding 5mM DTT and incubating in a 60°C water bath for 20 minutes. The Cysteines were then alkylated by adding 15mM N-Ethylmaleimide (NEM) and incubating for 20 minutes at room temperature. The alkylation reaction was stopped by adding 5mM DTT and incubating for 10 minutes at room temperature. Salts, small molecules, and lipids were removed by methanol-chloroform precipitation. The resulting protein pellet in each condition was dissolved in 90 mL 6M Guanidine hydrochloride (GuHCl) in 10mM EPPS (4-(2-Hydroxyethyl)-1 piperazinepropanesulfonic acid), pH 8.5. The protein concentration was determined to be 1.7 mg/mL using Pierce BCA Protein Assay Kit (Thermo Scientific). The sample was diluted to 2M GuHCl with 10mM EPPS pH 8.5 and digested overnight at room temperature with 10ng/mL LysC (Wako, 2 mg/mL stock in HPLC-treated water). The sample was further diluted to 0.5M GuHCl with 10mM EPPS pH 8.5. 10ng/mL LysC and 20ng/mL Trypsin (Promega) was added to the samples, which were then incubated at 37oC for 24 hours.

The samples were vacuum concentrated and resuspended in 90 mL of 20mM EPPS pH8.0. The conditions were labeled with 126 (0h), 127c (3.2 h), 128c (5.5 h), 129c (10.5 h) and 131 (21.5 h) TMT respectively by adding 40 mL of TMT reagent. All the conditions carrying the identification barcode were combined and vacuum concentrated to remove Acetonitrile (ACN). The sample was further acidified with 5% Phosphoric acid. Salts and undigested proteins were removed using C18 Sep-Pak (Water Corporations, 50 mg 1.3 mL column volume). The sample was eluted with 1mL of 70% ACN and 1% formic acid and then was further vacuum concentrated to remove acetonitrile. 10 mg of sample was taken up in 1% formic acid and 1 mg of that was analyzed on the mass spectrometer to confirm the quality of digestion and labeling.

The rest of each sample was resuspended in 450 mL of 10mM ammonium bicarbonate pH 8.0, 0.5% ACN and then pre-fractionated by medium pH reverse-phase HPLC using a flow rate of 0.5mL/min throughout. The gradient was 0% ACN for 18 minutes, then 7% to 35% ACN for 57 minutes, and then a flat gradient of 95% ACN for 5 minutes. Throughout prefractionation the pH was buffered with 10mM ammonium bicarbonate, pH 8.0. The fractions were collected using a fraction collector (Agilent 1260 Infinity) into a 96 well plate. The 96 fractions were pooled into 24 fractions by combining the alternating well from each column of the plate. Each fraction was vacuum concentrated and resuspended in 50 mL of 5% phosphoric acid. Stage-tip was performed to desalt the sample, and the sample was resuspended in 6 mL of 1% formic acid. 1.5 mL was analyzed by LC-MS.

#### HPLC and MS {#S23}

The instrument was equipped with an Easy nLC 1200 high pressure liquid chromatography (HPLC) pump. For each run, peptides were separated on a 100 mm inner diameter microcapillary column, packed first with approximately 0.5 cm of 5mm BEH C18 packing material (Waters) followed by 30 cm of 1.7mm BEH C18 (Waters). Separation was achieved by applying a 6%--30% ACN gradient in 0.125% formic acid and 2% DMSO over 90 min at 350 nL/min at 60°C. Electrospray ionization was enabled by applying a voltage of 2.6 kV through a microtee at the inlet of the microcapillary column.

The Orbitrap Fusion Lumos used the TMTc+ method ([@R86]). The mass spectrometer was operated in data-dependent mode with a survey scan ranging from 500--1400 m/z at resolution of 120k (200 m/z). 10 most intense ions for CID MS2 fragmentation using the quadrupole. Only peptides of charge state 2+ were included. Dynamic exclusion range was set to 60 s with mass tolerance of 10ppm. Selected peptides were fragmented using 32% HCD collision energy, and the resultant MS2 spectrum was acquired using the Orbitrap with a resolution of 60k and 0.4 Th isolation window.

### Primary antibody generation {#S24}

Anti-eIF4E and anti-CG3295 antibodies were raised in rat (Eurogentec). Antigens were prepared as follows: eIF4E1 IsoformA was expressed in *E. coli* as a His6-SUMO fusion protein. After metal affinity chromatography, the N-terminal SUMO domain was cleaved off with ULP protease, and the two protein fragments were separated by a second metal affinity column. CG3295 was expressed in *E. coli* as a His6 fusion protein. The protein was purified from inclusion bodies under denaturing conditions via metal affinity chromatography.

### Western blotting {#S25}

Primary antibodies used were: Guinea pig anti-SMG (1:20000), rabbit anti-SMG (1:500), rat anti-Cup (1:10000), rabbit anti-Cup (1:1000), rabbit anti-TRAL (1:5000), rat anti-TRAL (1:1000), rabbit anti-ME31B (1:1000 [Figure 2](#F2){ref-type="fig"}; 1:5000 others), rabbit anti-BEL (1:2000), Guinea pig anti-SLMB (1:4000), rat anti-CG3295 (1:500), rat anti-eIF4E (1:1000). Mouse anti-Tubulin (1:25000 [Figure 2](#F2){ref-type="fig"}; 1:20000 others) or mouse anti-Actin (1:1000) were used as loading controls.

For the developmental western blots shown in [Figures 2](#F2){ref-type="fig"} and [S2](#SD1){ref-type="supplementary-material"}, embryos were collected, dechorionated for 30 s in 12% sodium hypochlorite, weighed, homogenized in SDS sample buffer with a pestle and boiled for 5 min. Proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Blots were blocked at room temperature with 1.5% cold water fish gelatin (Sigma) in TBS for 1 hour, then incubated with primary antibodies diluted in 1.5% gelatin in TBST (TBS plus 0.05% Tween 20) at 4°C overnight. Subsequently, blots were washed 5 × 6 minutes with TBST at room temperature and incubated with the appropriate fluorescently labeled secondary antibodies (1:15000, Li-COR) in TBST at room temperature for 2 hours. Blots were washed 5 × 6 minutes with TBST, imaged using an Odyssey CLx scanner and Image Studio Lite software (LI-COR) and band intensities were quantified using ImageJ.

For all other western blots, dechorionated embryos were counted, then lysed in SDS-PAGE sample buffer at a concentration of 1 embryo/mL and boiled for 2 minutes. Proteins were resolved by SDS-PAGE and transferred to PVDF membrane. Blots were blocked at room temperature with 2% non-fat milk in PBST for 30 minutes and incubated with primary antibodies diluted in 2% non-fat milk in PBST at 4°C overnight. Subsequently, blots were washed 3 × 10 minutes with PBST at room temperature and incubated with the appropriate HRP-conjugated secondary antibodies (1:5000, Jackson ImmunoResearch) in 2% non-fat milk in PBST at room temperature for 1 hour. Blots were washed 3 × 15 minutes with PBST and developed using Immobilon Luminata Crescendo Western HRP substrate (Millipore), imaged using ImageLab (BioRad) and band intensities were quantified using ImageJ.

### MG132 treatment {#S26}

1--2 hour old embryos were permeabilized using a modification of a published method ([@R76]): Embryos were dechorionated for 30 s in 12% sodium hypochlorite. 45.25 mL of Modified Basic Incubation Medium (MBIM) ([@R89]) was mixed with 0.25 mL Triton X-100 and 4.5 mL (R)-(+)-limonene (Merck), the dechorionated embryos were incubated with this mix for 30 s and then washed extensively with PBS followed by PBS/0.05% Tween 20. They were then incubated in MBIM containing 100 mMMG132 + 0.05% DMSO or 0.05% DMSO only, for 3 hours at 25°C, washed in PBS, lysed in SDS-PAGE loading buffer, and analyzed by western blot.

### FLAG-SMG transgenes {#S27}

For generation of transgenic flies expressing FLAG-SMG and FLAG-SMG767D999, the base vector used was the *smg5*ʹ*UTR-BsiWI-smg3*ʹ*UTR* (*SBS*) plasmid ([@R95]). A linker carrying a start codon, the FLAG/p53 epitope tags, and *Asc*I and *Pme*I restriction sites was inserted into the *Bsi*WI site of *SBS*, between the *smg* UTRs. Genomic sequences of corresponding transgenic *smg* proteins were inserted between the *Asc*I and *Pme*I sites. Coding sequence for amino acids 1--999 (for expression of full-length FLAG-SMG) and for amino acids 1--766 (for expression of truncated FLAG-SMG767D999) were amplified from a *smg* genomic rescue construct ([@R18]) using a 5ʹ-primer with an *Asc*I linker and a 3ʹ-primer with a *Pme*I linker. The ORFs were inserted between the *Asc*I and *Pme*I sites in the SBS plasmid. *smg* genomic transgenes were then inserted into a pCaSpeR4 cloning vector with an attB site ([@R59]; [@R95]). Transgenic *smg* constructs were integrated into an attP40 landing site on the second chromosome (2L:25C7) ([@R59]) by Genetic Services (Cambridge, MA) using phiC31, a site-specific integrase ([@R33]). The inserted transgenes were then crossed into a *smg*^*47*^ mutant background ([@R13]).

### FLAG IP-MS {#S28}

#### Immunoprecipitation {#S29}

For FLAG-SMG IP-MS experiments, 0--3 hour old embryos were collected from flies expressing FLAG-SMG, FLAG-SMG767D999 or non-transgenic *w*^*1118*^ flies as control. Dechorionated embryos were crushed in a minimal volume of lysis buffer (150 mM KCl, 20 mM HEPES-KOH pH 7.4, 1 mM MgCl2, 0.1% Triton X-100, supplemented with protease inhibitors and 1 mM DTT), cleared by centrifugation for 15 minutes at 4°C and 20,000 × g, and stored at 80°C. Immediately prior to IP, the lysate was diluted twofold with lysis buffer and cleared again by centrifugation. Protein concentration was measured by Bradford Assay (Bio-Rad), and samples were adjusted with lysis buffer to equal concentrations. For each IP, 500 mL of diluted lysate, with or without 350 mg/mL RNase A, was mixed with 20 mL of anti-FLAG M2 beads (Sigma; blocked with 5mg/mL BSA) or Protein A beads as control, then incubated for \~3 hours at 4°C with end-over-end rotation. After incubation, beads were washed 4--5 times with lysis buffer, twice with lysis buffer lacking Triton X-100, then transferred to new tubes, and washed twice with lysis buffer lacking Triton X-100.

#### Sample preparation {#S30}

Bound proteins were eluted by tryptic digest: beads were resuspended in 200 mL of 50 mM ammonium bicarbonate, pH 8, with 2 mg of trypsin (Pierce), and incubated overnight at room temperature with end-over-end rotation. The digested supernatant was recovered, and beads were washed once with an additional 200 mL of 50 mM ammonium bicarbonate. The two eluates were pooled and dried by Speed-vac. Samples were desalted with C18 tip (Pierce C18 Spin Tips, Thermo Scientific cat. no. 84850) following the manufacturers' protocol and dried by Speed-vac. Samples were then resuspended in 26 mL of 1% (vol/vol) formic acid, and centrifuged at 13,200 RPM for 20 minutes. 22 mL was loaded into a 96 well plate, two 10 mL injections were made for each sample.

#### HPLC and MS {#S31}

For liquid chromatography the following solvents were used: Solvent A (0.1% (vol/vol) formic acid) and Solvent B (0.1% (vol/vol) formic acid/90% (vol/vol) acetonitrile). LC solvents were replaced a minimum of every 2 weeks. The LC parameters were set up using an Easy-nLC 1200 instrument. Peptides were loaded and separated on a nanoViper trap column (75 mm × 2 cm), Acclaim PepMap 100 (C18, 3 mm, 100Å,Thermo Scientific, cat. no. 164946) and EASY-Spray analytical column (75 mm × 50cm) Acclaim PepMap RSLC (C18, 2 mm, 100Å,Thermo Scientific) at a flow rate of 225nL/min. Tandem MS was performed using the Q Exactive HF-Orbitrap mass spectrometer (Thermo Scientific), as previously described ([@R14]; [@R46]; [@R55]; [@R61]). The parameters for acquisition were 1 MS scan (50 ms; mass range, 390 to 1800) at a resolution of 60,000K, followed by up to 20 MS/MS scans (50 ms each) at a resolution of 15,000 and an AGC target of 1×10^5^. Candidate ions with charge states +2 to +7 were isolated using a window of 1.4 amu with a 5 s dynamic exclusion window.

### GFP IP-MS {#S32}

#### Immunoprecipitation and sample preparation {#S33}

For GFP-tagged proteins, 0--2 hour old embryos were collected from flies expressing either GFP-SLMB, Muskelin-GFP or from non-transgenic Canton S flies as control. Embryos were dechorionated for 30 s in 12% sodium hypochlorite and lysed in 50 mM Tris pH 7.5, 150 mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate and protease inhibitor mix, by homogenization with a pestle on ice. The extract was cleared by centrifugation (20000 × g, 4°C), frozen in liquid nitrogen and stored at \~80°C. The lysate was treated with RNase A (100 mg/ml) for 10 min at room temperature, cleared again by centrifugation (20000 × g, 4°C) and diluted 1:5 with GFP wash buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA). The diluted extract was incubated with GFP-Trap matrix (Chromotek, equilibrated in GFP wash buffer) for 1 h at 4°C. The matrix was washed 3 times with GFP wash buffer and resuspended in 8 M urea/ 0.4 M ammonium bicarbonate. Bound proteins were reduced with DTT (7.5 mM, 30 min at 50°C), alkylated with chloroacetamide (20 mL 100 mM per 120 mL reduced sample, 30 min at room temperature), adjusted with water to 800 mL and digested with sequencing grade trypsin (Promega, 1:50 w/w trypsin to protein ratio) at 37°C overnight. Digests were separated from beads by centrifugation and stopped by addition of 40 mL 10% TFA. Samples were concentrated by Speed-vac.

#### HPLC and MS {#S34}

Samples were analyzed by LC-MS/MS using a U3000 RSCL nano-HPLC system coupled to an Orbitrap Q-Exactive Plus mass spectrometer with NanoFlex ionization source (all from Thermo Fisher Scientific). Samples were loaded on a trap column (PepMap RPC18, 300 mm × 5 mm, 5 mm, 100Å,Thermo Fisher Scientific) with 0.1% TFA at a flow rate of 30 mL/min. After 15 min, peptides were eluted via an in-house packed separation column (self-pack PicoFrits, 75 mm × 50 cm, 15 mm tip, New Objective, packed with ReproSil-Pur 120 C18-AQ, 1.9 mm, Dr. Maisch GmbH). For peptide separation, a linear 180-min gradient was applied (3% - 40% eluent B; eluent A: 0.1% formic acid in water, eluent B: 0.08 formic acid in acetonitrile) at a flow rate of 230 nL/min. Data were acquired using a data-dependent top10 strategy (one MS survey scan, followed by 10 MS/MS scans of the 10 most abundant signals). MS data (m/z range 375--1800) were recorded with R = 140,000 at m/z 200, MS/MS data (HCD, 28% normalized collision energy) with R = 17,500 at m/z 200.

### Maternal RNAi knockdown {#S35}

Females expressing the maternal-Gal4 driver (BDSC \#80361) were crossed to males expressing UAS-hairpin RNA targeting each gene assayed from the TRiP library (see [Experimental Model](#S18){ref-type="sec"}). UAS-hairpin RNA targeting mCherry was used as control knockdown. Adult F1s from these crosses were used for embryo collection. Maternal knockdown efficiency was assayed in 0--3 h embryos by RT-qPCR. In the case of *slmb* RNAi, depletion of *slmb* mRNA was incomplete; knockdown was, therefore, further validated by western blotting.

### RT-qPCR {#S36}

Total RNA was collected from dechorionated embryos in TRI Reagent (Sigma) following the manufacturer's protocol. 500 ng of total RNA per sample was used to synthesize cDNA with Superscript IV reverse transcriptase kit (Invitrogen) and the reaction was primed using random hexamers. The resultant reaction containing single-stranded cDNA was diluted 1:20 with RNase-free water and used for quantification by qPCR. Primers specific to the transcripts assayed were designed using NCBI Primer-BLAST to cover all isoforms and span an exon-exon junction ([Table S6](#SD1){ref-type="supplementary-material"}). Quantitative real-time PCR was performed on a CFX384 Real-Time System (Bio-Rad), using Sensifast SYBR PCR mix (Bioline) following the manufacturer's protocol and using 5 mL of diluted cDNA per reaction. Expression of each gene was averaged across three technical replicates per biological replicate and normalized to *RpL32* control.

### Immunostaining {#S37}

0--3 hour old embryos were collected from F1 adults from maternal RNAi crosses, dechorionated with 4.2% sodium hypochlorite for 2 minutes, then fixed in 4% formaldehyde and heptane for 20 minutes, and devitellinized by the addition of methanol and vigorous shaking. Fixed embryos were rehydrated by washing 4 times with PBSTx (PBS, 0.1% Triton X-100) and blocked with 10% bovine serum albumin (BSA) in PBSTx. Embryos were incubated with guinea pig anti-SMG (1:2000 dilution, 1% BSA in PBSTx) rocking overnight at 4°C and subsequently washed 3 × 15 minutes while rocking at room temperature. Embryos were then incubated in Cy3-conjugated donkey anti-guinea pig secondary antibody (1:300 dilution, 1% BSA in PBSTx; Jackson ImmunoResearch) for 1 hour rocking at room temperature, and washed 5 × 10 minutes with PBSTx. 0.001 mg/mL DAPI (Sigma) was added to the second wash to label DNA. Embryos were mounted in 2.5% DABCO (Sigma), 70% glycerol in PBS. Images were collected using a Zeiss AxioSkop-2 MOT fluorescence microscope and the QCapture Suite PLUS acquisition software.

### SMG target-RNA prediction {#S38}

To computationally predict the formation of SMG recognition element (SRE) stem/loops (CNGGN~0--4~ loop sequence on a non-specific stem) within a transcript, we used a multi-step pipeline modified from our previous method ([@R13]). Each transcript was first scanned with RNAplfold (ViennaRNA package version 2.3.1) using the parameters -W = 170 -L = 120 -T = 25 ([@R51]). Next, the transcript was scanned for CNGG motif (and variant motif) sites, and if the RNAplfold results indicated that the base immediately 5′ to the motif formed a base-pair interaction with one of the five nucleotides immediately 3′ to the motif with a probability \> 0.01, then the motif was marked for further analysis. The probability of stem/loop formation at each site was then assessed with RNA-subopt using a 120nt sliding window that overlapped the candidate site (the first window beginning at 75nt upstream of the motif and extending 40nt downstream of the motif, which was shifted by one nucleotide in the 3′ direction per window 34 times for a total of 35 windows), for which 3000 structures were sampled per window. The empirical probability of stem/loop formation for each site was averaged across the 35 windows and expressed as a percentage to produce a score for each motif; scores from individual motifs were then summed across the entire transcript to produce the final SRE score for the whole transcript. Zygotic targets not likely to be potential SMG targets had SRE scores \< 5. All SMG-bound targets assayed had SRE scores \> 10.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S39}
---------------------------------------

### Embryo developmental proteome {#S40}

A suite of software tools developed in the Gygi Lab was used to convert mass spectrometric data from the Thermo RAW file to the mzXML format, as well as to correct erroneous assignments of peptide ion charge state and monoisotopic m/z ([@R43]; [@R86]). We used RawFileReader libraries from Thermo, version 4.0.26 to convert the raw files into mzXML file format. Assignment of MS2 spectra was performed using the SEQUEST algorithm v.28 (rev. 12) by searching the data against the appropriate proteome reference dataset acquired from UniProt (*Drosophila melanogaster* with Proteome ID UP000000803, Protein count 21988 downloaded in July, 2017; *Saccharomyces cerevisiae* (yeast) with Proteome ID UP000002311, Organism ID 9606, Protein count 6049 downloaded in July, 2017) including 114 common contaminants like human Keratins and Trypsin. The MS spectrum to peptide mapping can be found on ProteomeXchange: PXD016523. This forward database component was followed by a decoy component which included all listed protein sequences in reversed order ([@R24]). Searches were performed using a 20-ppm precursor ion tolerance, where both peptide termini were required to be consistent with Trypsin or Lys-C specificity, while allowing one missed cleavage. Fragment ion tolerance in the MS2- spectrum was set at 0.02 Th. NEM was set as a static modification of cysteine residues (+125.047679 Da), TMT as a static modification of lysine residues and peptides' N-termini (+229.162932 Da), oxidation of methionine residues (+ 15.99492 Da) as a variable modification. An MS2 spectral assignment false discovery rate of 0.5% was achieved by applying the target decoy database search strategy. Filtering was performed using a Linear Discriminant analysis with the following features: SEQUEST parameters XCorr and unique D XCorr, absolute peptide ion mass accuracy, peptide length, and charge state. Forward peptides within three standard deviations of the theoretical m/z of the precursor were used as positive training set. All reverse peptides were used as negative training set. Linear Discriminant scores were used to sort peptides with at least seven residues and to filter with the desired cutoff. Furthermore, we performed a filtering step on the protein level by the "picked" protein FDR approach ([@R79]). Protein redundancy was removed by assigning peptides to the minimal number of proteins that could explain all observed peptides, with the above-described filtering criteria. TMTc+ data were analyzed as previously described ([@R86], 2018b). To correct for pipetting errors in the experiments, we normalized the signal such that the median peptide ratio between all the stages was 1:1:1:1:1.

### Assigning confidence intervals to the development proteome {#S41}

We used BACIQ (Bayesian Approach to Confidence Intervals for protein Quantitation) ([@R71]) to assign confidence to the relative expression of proteins at each developmental stage (<https://github.com/wuhrlab/BACIQ>). Specifically, we used the model version that shares the variances across all proteins. To obtain the most probable estimates and the confidence associated with a protein's expression at a stage, we fed the algorithm with the ions corresponding to that stage and the total ion counts in all other stages for all the underlying peptides of the given protein. To convert the peptide Signal/FT-noise signal into counts, a multiplicative factor of 2.1 (for 30k Orbitrap resolution) was used. The algorithm outputs the posterior distribution for the relative expression for every protein. The estimate is the median of the distribution and the confidence is given by 95% intervals.

### Estimated rank ordering of protein abundances {#S42}

To estimate the rank-ordering of protein abundance we followed a procedure previously described ([@R109]). We integrated each PSMs raw signal in MS1 over time with 10ppm tolerance using the GFY software licensed from Harvard University. The number of ions per PSM were summed for all PSMs that matched a protein, then normalized to the number of theoretically calculated tryptic peptides, with at least 7 and maximally 25 amino acids (missed cleavages were not allowed for theoretical peptides). We rank-ordered estimated protein abundances by this normalized integrated signal.

### k-means clustering {#S43}

k-means clustering was performed using the kmeans function in MATLAB 2019a with "Replicates" set to 30. The number of clusters was selected to 6 to capture overall protein dynamics. Further cluster increases did not reveal new cluster dynamics.

### Comparison of proteome to transcriptome datasets {#S44}

Cluster 4 and Cluster 6 proteins in the embryo proteome presented in this study were each compared to the transcriptome and translatome (ribosome-association) previously published in [@R22]. Scatterplots of these comparisons are presented in [Figures 1E](#F1){ref-type="fig"}--[1H](#F1){ref-type="fig"}. For consistency between datasets, genes associated with all transcripts analyzed were converted to FlyBase Gene IDs (FBgn) from FlyBase release 6.30. For each comparison, only genes expressed in both datasets were included in the scatterplots and statistical analyses. Proteins mapping to multiple genes were excluded. Minimum RPKM expression was set to 0.01, and minimum TE was set to 0.001 to avoid dividing by zero. Relationship between change in protein abundance and either change in transcript abundance or change in translation efficiency were determined statistically using Fisher's exact test. For genes in Cluster 4, proportion of proteins with R 2-fold increase in RNA level ([Figure 1E](#F1){ref-type="fig"}) or R 2-fold increase in translation efficiency ([Figure 1G](#F1){ref-type="fig"}) within the cluster were compared to their respective proportions within the entire proteome. For genes in Cluster 6, similar analyses were performed for R 2-fold decrease in protein level with the corresponding transcript's decreases in RNA level ([Figure 1F](#F1){ref-type="fig"}) or translation efficiency ([Figure 1H](#F1){ref-type="fig"}). *P* values for these associations are presented in the relevant figure panels, figure caption, and described in detail in the text.

### Gene set enrichment analysis {#S45}

Gene Ontology (GO) term enrichment analyses were carried out using the DAVID functional annotation tool online at <https://david.ncifcrf.gov/> ([@R41], [@R42]). Genes in each of the six clusters were analyzed against the background list of all expressed genes through all time points. For each cluster, Level 3 terms were selected for each of the 'molecular function', 'cellular component' and 'biological process' categories. For Cluster 6, Level 4 terms were subsequently selected to obtain more refined GO terms. A Benjamini *P*-value cut-off of 0.1 was used to report significantly enriched GO terms.

### Motif discovery {#S46}

Multiple Em for Motif Elicitation (MEME) ([@R4]) was used through The MEME Suite 5.1.1 at <http://meme-suite.org/>. Protein sequences were downloaded from UniProtKB. Motif discovery was performed in the discriminative mode using all 154 Cluster 6 proteins as primary sequences and either 2595 proteins, representing most of Cluster 1, or 394 RNA-binding and RNP-associated proteins within Cluster 1 as control sequences. Settings used specified up to 10 motifs of 4--12 residues in length. Motifs with E-value ≤ 10^−4^ are presented in [Figure S1](#SD1){ref-type="supplementary-material"}.

### FLAG IP-MS {#S47}

Biological replicates of FLAG IP-MS represent pull-downs performed on embryo lysate from independently collected embryo populations. For FLAG-SMG IP, four biological replicates were performed without RNase treatment, five biological replicates with RNase treatment. Two types of negative controls were used: Protein A IP from the same lysate expressing FLAG-SMG (two replicates), or FLAG pull-down from wild-type (*w*^*1118*^) embryo lysate (three replicates). The set of five control IPs was performed with or without RNase, and controls and IPs matching the same treatment conditions were used for analysis.

The ProHits software package ([@R54]) was used to perform peptide validation and protein interaction analysis. Proteins with associated peptide counts were filtered through the Trans Proteomic Pipeline (TPP) for iProphet probability \> 0.95 and number of unique peptides R 2 ([@R84]). Significance Analysis of INTeractome (SAINT) was used to determine the probability of each interacting protein ([@R15]). SAINTexpress was run on the ProHits interface using number of compressed controls = 3; nburn = 2000; niter = 5000; lowMode = 1; minFold = 1; normalize = 1; no bait compression. The average iProphet peptide counts for detected proteins in our FLAG-SMG IPs are presented in scatterplots in [Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}. For interacting proteins not detected in the negative control, average peptide count in the control IP is plotted as 0.1 (small number) to avoid taking the log of zero. Bayesian false discovery rates (BFDRs) from SAINT analysis for proteins of interest are also annotated in the figure panels and figure captions. A comprehensive list of peptide counts for each replicate, SAINT scores, and BFDR for all captured proteins can be found in [Table S4](#SD5){ref-type="supplementary-material"}.

Three biological replicates of FLAG-IP from embryos expressing FLAG-SMG767D999 were performed in parallel with three replicates of FLAG-SMG IPs and control (*w*^*1118*^) IPs, each treated with 350 mg/mL of RNase A. MS results from these FLAG-SMG767D999 IPs and control IPs were analyzed using the methods described above to determine interactors that were lost upon truncation of the SMG C terminus. Peptide counts, fold enrichment and SAINT analysis of interactors with SMG767D999 can be found in [Table S4](#SD5){ref-type="supplementary-material"}.

### GFP IP-MS {#S48}

Biological replicates of GFP IP-MS represent IPs performed on embryo lysate from independently collected embryo populations. Three biological replicates were performed for each genotype: embryos expressing Muskelin-GFP, embryos expressing GFP-SLMB, and wild-type (Canton S) embryos as negative control.

MS data were analyzed with MaxQuant 1.6.1.0 with label-free quantification ([@R17]). The modification parameter was set according to the alkylation reagent used, iBAQ values were reported and the different runs of an experiment were matched if applicable. Average iBAQ intensities for proteins detected in the GFP-IPs versus control IPs are presented as scatterplots in [Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}. For interacting proteins not detected in the negative control, average peptide count in the control IP is plotted as 10 (small number) to avoid taking the log of zero. *P*-values were calculated with a one-tailed, unpaired Student's t test. *P-*values are annotated for protein interactors of interest in the figure panels and figure captions. A comprehensive list of iBAQ intensities for each replicate, fold enrichment and *P-*values for all captured proteins can be found in [Table S5](#SD6){ref-type="supplementary-material"}.

### Determination of ubiquitination sites {#S49}

For determination of ubiquitination sites the MS raw data ([@R30]) were reanalyzed with Proteome Discoverer 2.4 (Thermo Fisher Scientific) using Sequest HT and MS Amanda 2.0 for database search against the amino acid sequences of TRAL, ME31B, SMG, Cup and Muskelin setting GG modification of lysines as variable modification. False discovery rates (FDRs) were determined by a target decoy approach. Only GG-modified peptides identified by both search engines Sequest HT and MS Amanda with high confidence (FDR \< 0.01) were considered as unambiguously ubiquitinated. Ubiquitination of these peptides was further confirmed by inspection of the relevant spectra. Analysis of ubiquitinated peptides is presented in [Table S3](#SD4){ref-type="supplementary-material"}.

### Quantification of western blots {#S50}

Developmental western blots ([Figures 2A](#F2){ref-type="fig"} and [S2](#SD1){ref-type="supplementary-material"}) were quantified using ImageJ. Each protein was normalized to the tubulin loading control, and the highest signal for each was set to 100. For RNAi experiments presented in [Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}, protein expression was assayed by western blot. For each knockdown at each time point, lysates equivalent to 10 embryos were run on SDS-PAGE for quantification. Three biological replicates, representing three independent embryo collections were assayed. Band intensities were quantified using ImageJ and normalized to a-Tubulin as loading control. For each replicate, intensities were normalized to the first time point (0--1 hour). Averages of the 3 replicates are presented in these figures with error bars representing standard deviation (Student's t test, two-tailed, unpaired). Significance thresholds are presented in the figures and figure captions.

### Quantification of RNA expression {#S51}

Quantitative real-time PCR (qPCR) data were analyzed using the CFX Manager software (Bio-Rad). For each of three biological replicates, representing three independent embryo collections, values from three technical replicates were averaged and relative gene expression was normalized to the ribosomal protein transcript *RpL32* as control. For gene expression analyses presented in [Figure 7](#F7){ref-type="fig"}, see below. For all other quantification of RNA expression, normalized expression is presented as the average of three replicates with error bars representing standard deviation (Student's t test, two-tailed, unpaired). Significance thresholds are presented in the figures and figure captions.

### Gene expression in FLAG-SMG767D999 {#S52}

Quantitative real-time PCR (qPCR) data were analyzed using the CFX Manager software (Bio-Rad). Expression of each gene of interest was assayed in two biological replicates per time point per genotype, representing two independent embryo collections of 50 embryos each. For each biological replicate, values from three technical replicates were averaged and relative gene expression was normalized to the ribosomal protein transcript *RpL32* as control. Expression of each gene was further normalized to the first time point (0--2.5h hours). Mean and standard deviation of normalized expression are presented in [Figure 7](#F7){ref-type="fig"}. For each group of genes (maternal, zygotic, re-expressed), differences in expression between the two genotypes were analyzed using the Wilcoxon signed-rank test. *P*-values for each gene group are presented in [Figure 7](#F7){ref-type="fig"}.
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![The Drosophila Proteome Is Dynamic during Embryogenesis\
(A) Venn diagram comparing the previously reported embryonic proteome ([@R11]) with that defined in this study. Our methods captured 97% of the genes reported in the previous study and proteins encoded by an additional 2,294 genes. These additional proteins rank significantly lower in abundance than those reported in both studies. A small number of proteins that mapped to multiple genes were excluded from this analysis.\
(B) k-means clustering (k = 6) for 7,956 quantified proteins through embryogenesis. Embryos were aged to five developmental time points at 22 C. The equivalent developmental times at 25 C for each sample are indicated on the x axis. The first three samples cover the MZT (gray box).\
(C) Expression profile of individual cluster 6 proteins (gray lines) through embryogenesis reveals the maternal nature of these proteins and their rapid clearance during the MZT, restricting their expression mostly to the early embryo. Profiles of SMG, Cup, TRAL, and ME31B are shown in color, highlighting the later timing of SMG's degradation relative to its co-repressors. Error bars indicate upper and lower limit of relative expression with a 95% Bayesian confidence interval at each time point.\
(D) Scatterplot comparing the degradation of cluster 6 proteins during the MZT in this study with that previously reported ([@R11]). 104 of our 154 cluster 6 proteins were also found in that study. Almost all cluster 6 proteins that decreased in expression during the MZT (time point 3/time point 1) showed a similar decrease in the previous report (4--5 h/0--1 h) (plotted in red). Note that proteins that decreased to undetectable levels by 4--5 h are plotted on the x axis. (E and F) Scatterplot of change in RNA expression (reads per kilobase of transcript, per million mapped reads \[RPKM\], 3--4 h/0--1 h) ([@R22]) versus change in protein expression (time point 3/time point 1) for dynamic proteins during the MZT. Genes corresponding to RNA with R2-fold decrease in expression are plotted in red; R2-fold increase in expression are plotted in blue.\
(E) Proteins that increased in expression during the MZT (cluster 4) showed a significant correspondence with R2-fold increase in their transcript expression (p \< 10 ^9^).\
(F) Proteins that decreased in expression (cluster 6) showed a significant correspondence with R2-fold decrease in their transcript expression during the MZT (p \< 10 ^22^).\
(G and H) Scatterplot of change in translational efficiency (TE, 3--4 h/0--1 h) ([@R22]) versus change in protein expression (time point 3/time point 1) for dynamic proteins during the MZT. Genes corresponding to RNA with R2-fold decrease in TE are plotted in red; R2-fold increase in TE is plotted in blue.\
(G) Cluster 4 proteins showed a significant correspondence with R2-fold increase in TE of their transcripts (p \< 10 ^3^).\
(H) Cluster 6 proteins were not associated with significant changes in TE of their transcripts (p = 0.206).Fisher's exact test was performed for (E)--(H). See also [Figure S1](#SD1){ref-type="supplementary-material"} and [Tables S1](#SD2){ref-type="supplementary-material"} and [S2](#SD3){ref-type="supplementary-material"}.](nihms-1607414-f0002){#F1}

![SMG, Cup, TRAL, and ME31B Are Degraded at Distinct Times during the MZT through the Ubiquitin-Proteasome System\
(A) Developmental western blot of wild-type embryos collected in 30-min time windows and aged at 15-min intervals over the first 6 h after egg lay (AEL). Cup, TRAL, and ME31B are notably decreased by around 1.5 h AEL, whereas SMG levels increase in the early embryo and are subsequently cleared by about 2.5 h AEL. BEL and eIF4E are present for the duration of the time course. Tubulin was probed as a loading control. See [Figure S2](#SD1){ref-type="supplementary-material"} for quantification.\
(B) Developmental western blot of wild-type embryos collected over the first 4 h of embryogenesis from mated females (fertilized) and unmated females (unfertilized). Degradation of Cup, TRAL, and ME31B are unaffected in unfertilized eggs, whereas SMG protein fails to be degraded by 3--4 h AEL.\
(C) Western blots of 1- to 2-h-old embryos that were permeabilized and incubated for 3 h in buffer, DMSO control, or 100 mM MG132 and aged to 4--5 h AEL. All four RBPs shown are stabilized by MG132 treatment. See also [Figures S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"}.](nihms-1607414-f0003){#F2}

![SMG Interacts with Repressor RBPs and Two Distinct E3 Ubiquitin Ligase Complexes\
(A and B) FLAG IP-MS of 0- to 3-h embryo lysate collected from transgenic flies expressing FLAG-SMG and homozygous for the deletion allele *smg*^*47*^. A combination of Protein A control IP and FLAG IP from non-transgenic embryo lysate was used as control. Average spectral counts are plotted for proteins detected at R1 in FLAG-SMG IP on average across at least four biological replicates. Significance of interactors was analyzed using SAINT and annotated for proteins of interest: \*p % 0.1, \*\*p % 0.05, \*\*\*p % 0.001, \^Bait (significance of interaction not applicable).\
(A) In the absence of RNase A, SMG exhibited significant interactions with the co-repressive complex: Cup, TRAL, ME31B, BEL, and eIF4E (red).\
(B) In the presence of RNase A, SMG retained significant interactions with its co-repressors Cup and TRAL, but not significantly with ME31B (red). The IP also captured RNA-independent interactions with two E3 ubiquitin ligase complexes: the CTLH complex (blue: Muskelin, RanBPM, CG6617, CG3295, CG31357, and CG7611) and the SCF complex (green: CUL1, SKPA, CG14317, and SLMB).\
(C and D) GFP IP-MS of 0- to 2-h lysate from embryos expressing either Muskelin-GFP or GFP-SLMB. GFP IP from non-transgenic embryo lysate was used as control. Average iBAQ intensities ([@R17]) for proteins across three biological replicates are plotted. Significance of enrichment in IP versus control was analyzed for each interactor using Student's t test and annotated for proteins of interest: \*p % 0.1, \*\*p % 0.05; \*\*\*p % 0.01, \^Bait.\
(C) Muskelin-GFP interacts with the RBPs (red) and other members of the CTLH complex (blue).\
(D) GFP-SLMB interacts with the RBPs (red) and other members of the SCF complex (green).\
Proteins not detected in control IPs were assigned an average spectral count of 0.1 (A and B) or an iBAQ value of 10 (C and D) to avoid log(0); these small values were at least 2-fold less than the lowest detected values across all experiments. See also [Tables S4](#SD5){ref-type="supplementary-material"} and [S5](#SD6){ref-type="supplementary-material"}.](nihms-1607414-f0004){#F3}

![The CTLH Complex Directs the Degradation of Cup, TRAL, and ME31B, but Not SMG\
(A--C) Quantified developmental western blots of RBP expression. Embryos were collected from maternal knockdown of CTLH complex members over the first 4 h AEL. Knockdown of *muskelin*, *ranBPM*, and *CG3295* each independently resulted in significant stabilization of Cup (A), TRAL (B), and ME31B (C) relative to control *mCherry* knockdown.\
(D) SMG protein degradation was unaffected by knockdown of the CTLH complex.\
\*p \< 0.05; n = 3; error bars indicate SD, Student's t test. n.s., not significant. Knockdown was confirmed by qRT-PCR ([Figure S3](#SD1){ref-type="supplementary-material"}). See also [Figures S4](#SD1){ref-type="supplementary-material"} and [S5](#SD1){ref-type="supplementary-material"}.](nihms-1607414-f0005){#F4}

![The SCF Complex Directs the Degradation of SMG, but Not Cup, TRAL, and ME31B\
(A--C) Quantified developmental western blots of RBP expression. Embryos were collected from maternal knockdown of SCF complex members over the first 4 h AEL. Cup (A), TRAL (B), and ME31B (C) protein degradation were unaffected by knockdown of the SCF complex.\
(D) Knockdown of *cul1*, *skpA*, and *slmb* each independently resulted in significant stabilization of SMG protein relative to control *mCherry* knockdown. \*p \< 0.05; n = 3; error bars indicate SD, Student's t test. n.s., not significant. Knockdown was confirmed by qRT-PCR ([Figure S6](#SD1){ref-type="supplementary-material"}). See also [Figure S7](#SD1){ref-type="supplementary-material"}.](nihms-1607414-f0006){#F5}

![Subunits of the E3 Ligase Com plexes Are Temporally Regulated during the MZT\
(A) Expression of subunits of the CTLH complex captured in the developmental proteome. Error bars indicate the upper and lower limit of relative expression with a 95% Bayesian confidence interval at each time point. Most subunits have relatively constant levels throughout embryogenesis, whereas levels of Muskelin are highest at the first time point and then decrease rapidly.\
(B) Western blot of embryos expressing Muskelin-GFP. Anti-GFP (top) confirmed rapid clearance of Muskelin-GFP from the embryo. Anti-CG3295 (bottom) confirmed its stable expression during the MZT.\
(C) Expression of subunits of the SCF complex captured in the developmental proteome. Error bars are the same as in (A). Most subunits exhibit relatively constant levels throughout embryogenesis, whereas levels of the F-box subunit CG14317 increased rapidly during the MZT and then decreased very rapidly by the end of the MZT, with peak levels coinciding with degradation of SMG protein.\
(D) Developmental western blot of control RNAi embryos, confirming the stable expression of SLMB during the MZT. Notably, the same blot shown here was used to confirm SLMB knockdown in [Figure S6](#SD1){ref-type="supplementary-material"}.](nihms-1607414-f0007){#F6}

![Persistent SMG Protein Downre gulates Zygotic Re-expression of Its Target Transcripts\
(A) Transgenic flies were generated expressing either FLAG-tagged full-length SMG or SMG767D999 truncated C-terminal to its SAMPHAT RNA-binding domain. Transgenes were under the control of endogenous regulatory elements.\
(B) Developmental western blots were performed on embryos collected from transgenic flies in the *smg*^*47*^ deletion mutant background. FLAG-SMG expression resembled that of endogenous SMG. SMG767D999 protein was stabilized and persisted through the MZT.\
(C--E) Embryos were collected from the transgenic flies at two time points during the MZT, and gene expression was assayed by qRT-PCR.\
(C) Expression of transcripts that depend on SMG for zygotic transcription was rescued by SMG767D999 to similar or higher levels than by full-length SMG. These transcripts are predicted not to be direct targets for SMG binding because they have low SRE scores (see [STAR Methods](#S13){ref-type="sec"}).\
(D) Degradation of SMG-bound target maternal transcripts was rescued by SMG767D999. Where transcripts were not completely degraded by FLAG-SMG, SMG767D999 persistence resulted in further degradation of these targets to significantly lower levels (rightmost six genes).\
(E) SMG-target maternal transcripts that are re-expressed zygotically were significantly down-regulated in their zygotic levels by persistence of SMG767D999. Wilcoxon signed rank test p values are shown for each gene group; two biological replicates for each gene; error bars indicate SD.](nihms-1607414-f0008){#F7}
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KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                                      SOURCE                                       IDENTIFIER
  ------------------------------------------------------------------------------------------------------------------------ -------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  Antibodies                                                                                                                                                            
  α-Cup rat polyclonal                                                                                                     Akira Nakamura                               [@R64]; RRID: AB_2568985
  α-ME31B rabbit polyclonal                                                                                                Akira Nakamura                               [@R63]; RRID: AB_2568986
  α-ME31B rabbit polyclonal                                                                                                Elmar Wahle                                  [@R38]
  α-TRAL rabbit polyclonal                                                                                                 Akira Nakamura                               [@R63]
  α-TRAL rat polyclonal                                                                                                    Elmar Wahle                                  [@R30]
  α-SMG guinea pig polyclonal                                                                                              Craig Smibert                                [@R95]
  α-SMG rabbit polyclonal                                                                                                  Elmar Wahle                                  [@R12]; RRID: AB_2567238
  α-BEL rabbit polyclonal                                                                                                  Elmar Wahle                                  [@R30]
  α-SLMB guinea pig polyclonal                                                                                             Gregory Rogers                               [@R10]; RRID: AB_2567136
  α-eIF4E rat polyclonal                                                                                                   This paper                                   N/A
  α-CG3295 rat polyclonal                                                                                                  This paper                                   N/A
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###### Highlights

-   Early Drosophila embryos degrade 2% of their maternally encoded proteome

-   The Cup-TRAL-ME31B-Smaug post-transcriptional repressive complex is cleared

-   Distinct E3 ubiquitin ligases target Cup-TRAL-ME31B (CTLHE3) versus Smaug (SCF E3)

-   Failure to degrade Smaug abrogates an orderly maternal-tozygotic transition
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